Captain T Cell key facts
- Operator of a T-cell therapy firm intended for drug discovery.
- It has raised $9.2M; the latest was Early Stage VC in Oct 2025.
- Notable investors include Creative Destruction Lab, Brandenburg Kapital, Ascenion, Bundesministerium für Bildung und Forschung, HIL-INVENT — 11 tracked in total.
- Status: Privately Held (backing).
Who backs Captain T Cell
11+- ·The complete investor list: 11 names
- ·Watch Captain T Cell: the Monday email on marks, rounds and moves
Captain T Cell funding rounds
No funding rounds for Captain T Cell are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Captain T Cell investors
11 investors are on record for Captain T Cell, including Creative Destruction Lab, Brandenburg Kapital, Ascenion and Bundesministerium für Bildung und Forschung.
About Captain T Cell
Operator of a T-cell therapy firm intended for drug discovery. The company develops efficacy-enhanced therapies against solid tumors not addressed by existing treatments, enabling patients to treat their cancer diagnosis.
- Sector
- Healthcare
- HQ
- Berlin, Germany
- Founded
- 2019
- Employees
- 10
- Website
- captaintcell.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Captain T Cell doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.